TP53 and lung adenocarcinoma: Since the occurrence of isolated TP53 mutation remains a rare event in lung adenocarcinoma, a multi‐institutional study may be necessary to expand the investigation on the clinical, therapeutic, and prognostic implications of an isolated TP53 mutation in this lung tumor.